Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$16M |
| 3 |
JD.com
JD
|
+$15.8M |
| 4 |
Tyson Foods
TSN
|
+$15.6M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$44.2M |
| 2 |
Alibaba
BABA
|
+$34.5M |
| 3 |
AGN
Allergan plc
AGN
|
+$24.6M |
| 4 |
Fidelity National Information Services
FIS
|
+$22.3M |
| 5 |
Danaher
DHR
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 10.42% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Technology | 7.81% |
| 5 | Communication Services | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Entravision Communication
EVC
$745M
| $231K | 0.01% |
35,632
-64,105
| -64% | -$361K |
|
1202
CorVel
CRVL
$3.54B
| $230K | 0.01% |
+18,507
| New | +$213K |
|
1203
Tower Semiconductor
TSEM
$25.2B
| $230K | 0.01% |
+17,256
| New | +$194K |
|
|
BLCM
1204
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $230K | 0.01% |
+1,000
| New | +$214K |
|
1205
Jazz Pharmaceuticals
JAZZ
$16.5B
| $229K | 0.01% |
1,400
-200
| -13% | -$33.2K |
|
|
TCS
1206
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $229K | 0.01% |
+799
| New | +$231K |
|
|
EV
1207
DELISTED
Eaton Vance Corp.
EV
| $229K | 0.01% |
5,600
-2,205
| -28% | -$86.7K |
|
|
GST
1208
DELISTED
Gastar Exploration Inc.
GST
| $229K | 0.01% |
95,090
+14,952
| +19% | +$54.5K |
|
1209
Motorcar Parts of America
MPAA
$226M
| $228K | 0.01% |
7,319
-564
| -7% | -$17K |
|
1210
Target
TGT
$75.1B
| $228K | 0.01% |
+3,000
| New | +$203K |
|
|
POLY
1211
DELISTED
Plantronics, Inc.
POLY
| $228K | 0.01% |
4,300
-800
| -16% | -$40.2K |
|
1212
Stanley Black & Decker
SWK
$15.1B
| $226K | 0.01% |
+2,357
| New | +$217K |
|
1213
HNI Corp
HNI
$3.55B
| $225K | 0.01% |
4,400
-2,900
| -40% | -$131K |
|
|
VAR
1214
DELISTED
Varian Medical Systems, Inc.
VAR
| $225K | 0.01% |
2,965
-1,711
| -37% | -$127K |
|
|
BMS
1215
DELISTED
Bemis
BMS
| $225K | 0.01% |
+4,983
| New | +$201K |
|
|
ACRE
1216
Ares Commercial Real Estate
ACRE
$265M
| $224K | 0.01% |
19,520
-500
| -2% | -$5.93K |
|
|
STJ
1217
DELISTED
St Jude Medical
STJ
| $224K | 0.01% |
3,452
-20,604
| -86% | -$1.33M |
|
1218
Merit Medical Systems
MMSI
$5.42B
| $223K | 0.01% |
12,841
-39,251
| -75% | -$581K |
|
|
SA
1219
Seabridge Gold
SA
$3.25B
| $223K | 0.01% |
+29,583
| New | +$223K |
|
1220
Intrepid Potash
IPI
$525M
| $222K | 0.01% |
+1,603
| New | +$222K |
|
1221
Myriad Genetics
MYGN
$306M
| $222K | 0.01% |
6,518
-1,458
| -18% | -$51.7K |
|
1222
Oxford Industries
OXM
$540M
| $222K | 0.01% |
4,030
-1,954
| -33% | -$119K |
|
1223
First Financial Bancorp
FFBC
$3.47B
| $221K | 0.01% |
+11,880
| New | +$205K |
|
1224
Walker & Dunlop
WD
$1.38B
| $221K | 0.01% |
12,590
+650
| +5% | +$10.3K |
|
1225
Gentex
GNTX
$4.98B
| $220K | 0.01% |
12,200
-17,212
| -59% | -$286K |
|
Similar funds
Paul Tudor Jones's Q4 2014 Portfolio in Review
As of Q4 2014, Paul Tudor Jones held 1,750 positions worth $2.88B, up 3.7% from $2.77B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Paul Tudor Jones's Q4 2014 filing shows 423 new, 490 increased, 477 reduced and 333 closed positions. Its largest new stake was LinkedIn Corporation: 61,500 shares worth $14.1M. The largest sale was Zimmer Biomet, an estimated $44.2M.
By sector, the portfolio is most concentrated in Industrials at 10% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Paul Tudor Jones's largest Q4 2014 buy was LinkedIn Corporation: 61,500 shares worth $14.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $128M increase.
- Paul Tudor Jones's biggest Q4 2014 reduction was Zimmer Biomet, cutting an estimated $44.2M.
- Paul Tudor Jones fully exited Fidelity National Information Services in Q4 2014, selling an estimated $22.3M.
- Paul Tudor Jones's ten largest holdings make up 45% of its $2.88B portfolio in Q4 2014.
- Paul Tudor Jones opened 423 new positions and closed 333 in Q4 2014.
- Paul Tudor Jones's portfolio value rose 3.7% quarter-over-quarter to $2.88B.
Based on Tudor Investment Corp's 13F filing for Q4 2014, filed 17 Feb 2015.